Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow-to-Debt Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow-to-debt ratio. Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow-to-Debt Ratio of -0.14x as of December 2025, meaning its operating cash flow of CN¥-26.19 Million could theoretically repay 0% of its total liabilities (CN¥181.12 Million) in one year. Check 301089 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
Cash flow-to-debt ratio of Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2025. Historical debt coverage capacity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 7 annual periods. Check 301089 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow-to-Debt Ratio by Year (2019–2025)
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For the full cash flow conversion analysis, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | CN¥-26.19 Million | CN¥181.12 Million | ▼ -129.0% |
| 2024 | 0.50x | CN¥102.67 Million | CN¥205.72 Million | ▲ +336.5% |
| 2023 | 0.11x | CN¥26.95 Million | CN¥235.72 Million | ▼ -80.1% |
| 2022 | 0.58x | CN¥268.85 Million | CN¥466.89 Million | ▲ +193.2% |
| 2021 | 0.20x | CN¥58.19 Million | CN¥296.35 Million | ▼ -25.4% |
| 2020 | 0.26x | CN¥120.00 Million | CN¥455.61 Million | ▲ +8.8% |
| 2019 | 0.24x | CN¥86.38 Million | CN¥356.74 Million | — |